Financhill
Buy
60

ATRA Quote, Financials, Valuation and Earnings

Last price:
$15.63
Seasonality move :
5.9%
Day range:
$15.50 - $17.01
52-week range:
$6.50 - $39.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.97x
P/B ratio:
--
Volume:
72.1K
Avg. volume:
103.2K
1-year change:
19.14%
Market cap:
$95.2M
Revenue:
$8.6M
EPS (TTM):
-$25.76

Earnings Data

Next earnings date for ATRA
Mar 28
2025
Most recent earnings per share
-$2.93
Beat by $14.34
(Nov 12/2024)
Consensus Estimate
-$17.27
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ATRA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $37.4M -- -- -$0.16 --
03/28/2025 Q4 $33.1M -- -- -$2.34 --
11/12/2024 Q3 $35.2M $40.2M -$2.93 -$17.27 $14.34
08/12/2024 Q2 $37.1M $28.6M -$3.10 -$2.24 -$0.86
05/09/2024 Q1 $24.7M $27.4M -$5.75 -$6.42 $0.67
03/28/2024 Q4 $14.3M $4.3M -$13.98 -$12.05 -$1.93
11/01/2023 Q3 -- -- -$16.40 -$16.40 --
08/08/2023 Q2 -- -- -$16.91 -$16.51 -$0.40
05/08/2023 Q1 -- -- -$18.00 -$9.51 -$8.49
02/08/2023 Q4 -- -- -$18.00 -$9.70 -$8.30
11/08/2022 Q3 -- -- -$20.50 -$19.34 -$1.16
08/08/2022 Q2 -- -- $4.50 -- --
05/05/2022 Q1 -- -- -$21.75 -- --
02/28/2022 Q4 -- -- -$24.00 -- --
11/04/2021 Q3 -- -- -$22.50 -- --
08/09/2021 Q2 -- -- -$22.75 -- --
05/04/2021 Q1 -- -- -$21.50 -- --
03/01/2021 Q4 -- -- -$23.75 -- --
11/09/2020 Q3 -- -- -$23.00 -- --
08/05/2020 Q2 -- -- -$28.50 -- --
05/06/2020 Q1 -- -- -$30.00 -- --
02/27/2020 Q4 -- -- -$34.00 -- --
11/07/2019 Q3 -- -- -$32.75 -- --
08/08/2019 Q2 -- -- -$40.00 -- --
05/09/2019 Q1 -- -- -$36.00 -- --
02/26/2019 Q4 -- -- -$43.75 -- --
11/06/2018 Q3 -- -- -$32.25 -- --
08/01/2018 Q2 -- -- -$28.75 -- --
05/08/2018 Q1 -- -- -$26.25 -- --
02/27/2018 Q4 -- -- -$28.75 -- --
11/09/2017 Q3 -- -- -$25.50 -- --
08/07/2017 Q2 -- -- -$23.50 -- --
05/04/2017 Q1 -- -- -$22.00 -- --
03/09/2017 Q4 -- -- -$15.75 -- --
11/04/2016 Q3 -- -- -$22.00 -- --
08/08/2016 Q2 -- -- -$16.50 -- --
05/05/2016 Q1 -- -- -$14.50 -- --
03/03/2016 Q4 -- -- -$18.75 -- --
11/11/2015 Q3 -- -- -$10.75 -- --
08/06/2015 Q2 -- -- -$15.50 -- --
05/28/2015 Q1 -- -- -$10.50 -- --

Atara Biotherapeutics Earnings Questions

  • How Much did Atara Biotherapeutics Generate in Revenue Last Quarter?

    Atara Biotherapeutics reported $40.2M worth of top line sales in its most recent quarter.

  • Did Atara Biotherapeutics Beat Earnings Last Quarter?

    Atara Biotherapeutics announced earnings per share of -$2.93 which represents a beat of analyst forecast a -$17.27 per share.

  • Is Atara Biotherapeutics Profitable?

    Atara Biotherapeutics reported $32.6M that represents $4.36 per share over the last quarter.

  • What is the Analyst Consensus for Atara Biotherapeutics EPS Next Year?

    Atara Biotherapeutics's earnings are forecast to decrease from -$65.25 per share to -$1.52 per share next year representing a decrease of -91.07%.

  • When is Atara Biotherapeutics's Earnings Date?

    Atara Biotherapeutics's next earnings date is March 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 7.07% over the past day.

Sell
47
CEG alert for Jan 10

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
8
CRNX alert for Jan 10

Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock